Melipharm Overview
- Founded
-
2009
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Angel
- Investors
-
1
Melipharm General Information
Description
Developer of sterile medical devices intended for the treatment of acute and chronic wounds. The company's sterile medical devices are a natural product that comes from the selection of honey essences whose anti-bacterial and healing properties have been validated by the researchers in the laboratory, enabling doctors to treat acute and chronic wounds based on selected monofloral honey.
Contact Information
Primary Industry
Other Devices and Supplies
Other Industries
Personal Products
Pharmaceuticals
Primary Office
- 1 avenue d'Ester
- Cedex 3
- 87069 Limoges
- France
+33 07 00 00 00 00
Melipharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 01-Oct-2014 | 00000 | Completed | Generating Revenue | ||
| 2. Angel (individual) | 24-Jan-2012 | 00000 | 00000 | 00000 | Completed | Startup |
| 1. Angel (individual) | 27-Jul-2009 | $140K | $140K | 00000 | Completed | Startup |
Melipharm Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 000.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.00 | |
| Ordinary | 0,000 | 000.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Melipharm Patents
Melipharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4032542-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide | Inactive | 14-May-2014 | 0000000000 | 00 |
| EP-3142687-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxydase and zinc oxide | Inactive | 14-May-2014 | 0000000000 | |
| FR-3020948-A1 | Antimicrobial composition | Active | 14-May-2014 | 0000000000 | 0 |
| FR-3020948-B1 | Antimicrobial composition | Active | 14-May-2014 | 0000000000 | |
| US-20170072024-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide | Inactive | 14-May-2014 | A61K38/443 |
Melipharm Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Celine Archer | President |
Melipharm Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Melipharm Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Limousin Business Angels | Angel Group | Minority | 000 0000 | 000000 0 |